In the ever-evolving healthcare landscape, introducing a “New Pain Medication” brings both promise and scrutiny. As medical science advances, so do the options for pain management, yet the arrival of novel treatments prompts critical evaluation of their implications. The Role of New Pain Medication The advent of a “New Pain Medication” marks a significant milestone … Read more
Northwestern Medicine researchers found that RNA interference controls cell death in Alzheimer’s disease, a significant finding. The first short strands of toxic RNAs linked to brain cell death and DNA damage in Alzheimer’s and elderly brains have been identified. Paradigm Shift in Alzheimer’s Treatment The study shows that protective RNA strands decrease with age, which … Read more
Since 1961, early heart disease mortality has dropped by three-quarters, but the latest British Heart Foundation data shows a worrying reverse. Premature cardiovascular mortality is at a 10-year high, raising concerns about the pandemic, poor lifestyle choices, and healthcare issues. Lifestyle Choices and Health Service Challenges One plausible explanation for the surge in cardiovascular deaths … Read more
A groundbreaking randomized trial has showcased significant advancements in systemic therapy for unresectable liver cancer. The addition of durvalumab (Imfinzi) and bevacizumab (Avastin) to transarterial chemoembolization (TACE) has nearly doubled the median progression-free survival (PFS) for patients. The EMERALD-1 trial demonstrated that individuals receiving this combination had a median PFS of 15.0 months compared to … Read more
As worries rise over widespread PFAS (per- and polyfluoroalkyl substances) exposure, the CDC recommends clinicians test patients’ blood for these persistent and dangerous chemicals. Studies show that 98% of Americans may have PFAS in their blood, but the CDC wants to use blood testing to assess the problem and advise healthcare practitioners on risk mitigation. … Read more
Dr. Nia Heard-Garris of Northwestern University undertook a comprehensive evaluation that found continuing healthcare inequities for racial and ethnic minority children compared to white children across pediatric disciplines. The Lancet Child & Adolescent Health’s two-part series on racism and child health illuminates disparities in neonatology, primary care, emergency medicine, inpatient and critical care, surgery, developmental … Read more